Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...

During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Q4 2024 Earnings Call Transcript March 10, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is ...

Black seed oil has been used for centuries in traditional Eastern European, Northern African, and Southwestern Asian medicine. But what is black seed oil good for? It’s still generating buzz today for ...

Due to the physical, psychological, and socioeconomic consequences of a cancer diagnosis and treatment, people with cancer are especially vulnerable during extreme weather events like hurricanes, ...

A new editorial was published in , Volume 16, on March 10, 2025, titled "EXPOSOMES and GENES: The duo influencing CANCER initiation and progression." ...

Certain foods and habits can impact your chances of getting cancer in your lifetime. Here, we share the latest research as ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...

Among those with a TBS score less than 6 and node-negative disease, 5-year OS was similar between those receiving AC and those who did not.

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...